WuXi Biologics receives ESG Corporate Platinum Award from The Asset for fourth consecutive year
October 16, 2024 | 19:00
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization, today announced that it has received a Platinum Award from The Asset ESG Corporate Awards for the fourth year in a row.
Mobile Version